James Dru

Tolerability of Fosaprepitant and Bioequivalency to Aprepitant in Healthy Subjects

Kenneth C. Lasseter, Jay J. Gambale, Bo Jin et al. · The Journal of Clinical Pharmacology · 2007 · 133 citations

Pharmacy, Pharmacokinetics, Pharmacology +14

Assessment of the CYP3A‐Mediated Drug Interaction Potential of Anacetrapib, a Potent Cholesteryl Ester Transfer Protein (CETP) Inhibitor, in Healthy Volunteers

Rajesh Krishna, Arthur Bergman, Bo Jin et al. · The Journal of Clinical Pharmacology · 2008 · 38 citations

Pharmacy, Pharmacokinetics, Pharmacology +10

Metabolism and Excretion of Anacetrapib, a Novel Inhibitor of the Cholesteryl Ester Transfer Protein, in Humans

Sanjeev Kumar, Eugene Y. Tan, Georgy Hartmann et al. · Drug Metabolism and Disposition · 2009 · 35 citations

Pharmacy, Pharmacokinetics, Pharmacology +12

Determination of felodipine, its enantiomers, and a pyridine metabolite in human plasma by capillary gas chromatography with mass spectrometric detection

James Dru, John Y.‐K. Hsieh, B.K. Matuszewski et al. · Journal of Chromatography B Biomedical Sciences and Applications · 1995 · 32 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +17

Determination of a novel substance P inhibitor in human plasma by high-performance liquid chromatography with atmospheric pressure chemical ionization mass spectrometric detection using single and triple quadrupole detectors

M.L. Constanzer, C.M. Chavez-Eng, James Dru et al. · Journal of Chromatography B · 2004 · 27 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +16